Patient acceptance of a novel electronic auto-injector device to administer recombinant human growth hormone: results from an open-label, user survey of everyday use

Author： Dahlgren J.   Veimo D.   Johansson L.   Bech I.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.23, Iss.7, 2007-07, pp. : 1649-1655

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Controlled release of bioactive recombinant human growth hormone from PLGA microparticles

By Rafi Md.   Singh Surinder M.   Kanchan Vibhu   Anish C. K.   Panda Amulya K.  

Journal of Microencapsulation, Vol. 27, Iss. 6, 2010-09 ,pp. : 552-560

Informa Healthcare

Access to resources Recommend Favorite

Nuts! I Can't Figure Out How to Use My Life-Saving Epinephrine Auto-Injector!

By Gosbee Laura Lin  

Joint Commission Journal on Quality and Patient Safety, Vol. 30, Iss. 4, 2004-04 ,pp. : 220-223

Joint Commission Resources

Access to resources Recommend Favorite

Changes in schizophrenia-related hospitalization and ER use among patients receiving paliperidone palmitate: results from a clinical trial with a 52-week open-label extension (OLE)

By Kozma Chris M.   Slaton Terra   Dirani Riad   Fastenau John   Gopal Srihari   Hough David  

Current Medical Research and Opinion, Vol. 27, Iss. 8, 2011-08 ,pp. : 1603-1611

Informa Healthcare

Access to resources Recommend Favorite

Results of a phase I/II open‐label, safety and efficacy trial of coagulation factor IX (recombinant), albumin fusion protein in haemophilia B patients

By  

HAEMOPHILIA, Vol. 21, Iss. 6, 2015-11 ,pp. : 784-790

John Wiley & Sons Inc

Access to resources Recommend Favorite

BSACI guideline: prescribing an adrenaline auto‐injector

By  

CLINICAL & EXPERIMENTAL ALLERGY, Vol. 46, Iss. 10, 2016-10 ,pp. : 1258-1280

John Wiley & Sons Inc

Access to resources Recommend Favorite